
Alzheimer’s pill could reduce brain decline in some high-risk patients, trial suggests
Fox News
New research shows that the ALZ-801 pill effectively slows cognitive decline and brain shrinkage in mild cognitive impairment patients with APOE4 gene.
"It may well have a future as part of the growing arsenal of anti-Alzheimer’s drugs." Melissa Rudy is senior health editor and a member of the lifestyle team at Fox News Digital. Story tips can be sent to melissa.rudy@fox.com.
Researchers at Alzheon, Inc., a Massachusetts biotech company, conducted a phase 3 trial that included 325 people with early Alzheimer’s — either mild cognitive impairment (MCI) or mild dementia — all of whom carried the APOE4 gene, according to a press release.
More Related News













